|1.||Matsuo, Hirotaka: 3 articles (04/2010 - 07/2007)|
|2.||Kanai, Yoshikatsu: 2 articles (03/2015 - 09/2007)|
|3.||Masuko, Takashi: 2 articles (01/2013 - 05/2008)|
|4.||Masuko, Kazue: 2 articles (01/2013 - 05/2008)|
|5.||Aida, Shinsuke: 2 articles (04/2010 - 09/2007)|
|6.||Nakanishi, Kuniaki: 2 articles (04/2010 - 09/2007)|
|7.||Ogata, Sho: 2 articles (04/2010 - 09/2007)|
|8.||Hiroi, Sadayuki: 2 articles (04/2010 - 09/2007)|
|9.||Tominaga, Susumu: 2 articles (04/2010 - 09/2007)|
|10.||Kawai, Toshiaki: 2 articles (04/2010 - 09/2007)|
01/01/2013 - "The L-type amino acid transporter-1 (LAT1, SLC7A5) is upregulated in a wide range of human cancers, positively correlated with the biological aggressiveness of tumors, and a promising target for both imaging and therapy. "
04/01/2010 - "LAT1 protein was detected with a diffuse or granular appearance within the cytoplasm and/or on the plasma membrane of tumor cells. "
01/01/2010 - "Median age at diagnosis was 57, 71% were postmenopausal, 23.9% were node-positive and median tumor size was 1.5 cm. Samples were stained using triplicate 0.6 mm2 tissue microarray cores, and positivity for p53, HTF9C, CEACAM5, NDRG1 and SLC7A5 was assessed. "
09/01/2007 - "Further, in all tumors, a cooperative expression of LAT1 protein and 4F2hc protein was significantly correlated with both overall and disease-free survival rates in the univariate analysis but not in the multivariate analysis. "
09/01/2007 - "In tumor cells, LAT1 protein was detected either as nodular granules within the cytoplasm or diffusely within the cytoplasm and/or on plasma membrane. "
|2.||Hepatocellular Carcinoma (Hepatoma)
01/01/2016 - "We also show that high expression of SLC38A1 and SLC7A5 is significantly associated with shorter survival in hepatocellular carcinoma patients. "
05/01/2008 - "Two mAb were selected from hybridoma clones established by fusing mouse myeloma cells and spleen cells from rats immunized against RH7777 rat hepatoma cells expressing recombinant green fluorescent protein fused to human LAT1 protein. "
07/01/2007 - "The expression of amino acid transporter (AT) mRNAs including A system (ATA1/SNAT1/SLC38A1, ATA2/SNAT2/SLC38A2 and ATA3/SNAT3/SLC38A4), L system (LAT1/SLC7A5 and LAT2/SLC7A8), and y+ (CAT2/SLC7A2) genes, were compared among hepatocellular carcinoma (HCC) and non-cancerous liver cells. "
01/01/2015 - "Of the canonical changes noted, promoter (PR) DM loci with reciprocal changes in expression in adenocarcinomas included HBEGF, AGER, PTPRM, DPT, CST1, MELK; DM GB loci with concordant changes in expression included FOXM1, FERMT1, SLC7A5, and FAP genes. "
10/01/2014 - "The target DEGs of has-miR-7 were SNCA and SLC7A5 in adenocarcinoma and small cell lung cancer, respectively. "
08/01/2009 - "Five of these antibodies, targeting the proteins TRIM29, CEACAM5, SLC7A5, MUC1, and CK5/6, were combined into one test using a weighted algorithm trained to discriminate adenocarcinoma from squamous cell carcinoma. "
|4.||Small Cell Lung Carcinoma (Small Cell Lung Cancer)
|5.||Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
|1.||Amino Acid Transport Systems (Amino Acid Transporter)
|2.||Small Untranslated RNA
|4.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|5.||GTP Phosphohydrolases (GTPases)
|6.||Complementary DNA (cDNA)
|7.||Interleukin-8 (Interleukin 8)
|10.||Messenger RNA (mRNA)
|1.||Stem Cell Transplantation